Bharat Biotech COVID-19 vaccine gets govt panel nod for emergency use: Experts express concern
Recommendation to drug controller for emergency approval to India’s indigenous product against COVID-19
COVID-19 Vaccine Watch: India tops number of COVID-19 vaccine doses arranged from manufacturers
However, in terms of the proportion of the population that can be vaccinated with these doses, Canada leads the charts
Where are the vaccines for UP’s May 1 COVID-19 vaccination drive
There is extreme shortage of COVID-19 vaccines in India’s largest state and its government is facing problems in procuring them
Centre signs deal with Serum Institute for 11 million COVID-19 vaccine doses: Sources
Talks on with Bharat Biotech; no official statement from government or manufacturers yet
COVID-19 vaccination begins in Bihar; 30,000 health workers to be inoculated today
The vaccination will be staggered over three phases with health and frontline workers and people of 50 to get the shot first
Why experts are not happy with India’s COVID-19 vaccine procurement, pricing policy
India only COVID-19 vaccine producer that has shifted burden onto citizens to pay for vaccines by opening private markets for them, experts say
Covaxin effective against UK Strain: What does this mean in absence of efficacy data?
Being a whole-virus vaccine doesn’t give Bharat Biotech product any advantage at this stage, say experts
Gujarat recipients gung-ho on COVID-19 vaccine
The state will vaccinate about 440,000 healthcare workers and 355,000 frontline workers in the first round
COVID-19 immunity: how long does it last?
In UK’s second wave, previously infected health workers were either completely protected from reinfection or were asymptomatic
The curious case of Covaxin royalties
ICMR’s contradictions and obfuscation on ownership of the vaccine’s intellectual property is not helping in the fight against COVID-…
DCGI clears Bharat Biotech, SII COVID-19 vaccines but efficacy question unanswered
CDSCO official says BB vaccine to be used in public but to exclude people with COVID-19, other infections
Decision on emergency authorisation for SII, Bharat Biotech’s COVID-19 vaccines deferred
Both manufacturers have been asked for more data before a final decision can be reached
Bharat Biotech COVID-19 vaccine claimed to have 80.6% efficacy
'Shot well tolerated in participants; adverse events balanced between vaccine and placebo arms of the trial'